Gfi1b controls integrin signaling-dependent cytoskeleton dynamics and organization in megakaryocytes

Haematologica. 2017 Mar;102(3):484-497. doi: 10.3324/haematol.2016.150375. Epub 2017 Jan 12.

Abstract

Mutations in GFI1B are associated with inherited bleeding disorders called GFI1B-related thrombocytopenias. We show here that mice with a megakaryocyte-specific Gfi1b deletion exhibit a macrothrombocytopenic phenotype along a megakaryocytic dysplasia reminiscent of GFI1B-related thrombocytopenia. GFI1B deficiency increases megakaryocyte proliferation and affects their ploidy, but also abrogates their responsiveness towards integrin signaling and their ability to spread and reorganize their cytoskeleton. Gfi1b-null megakaryocytes are also unable to form proplatelets, a process independent of integrin signaling. GFI1B-deficient megakaryocytes exhibit aberrant expression of several components of both the actin and microtubule cytoskeleton, with a dramatic reduction of α-tubulin. Inhibition of FAK or ROCK, both important for actin cytoskeleton organization and integrin signaling, only partially restored their response to integrin ligands, but the inhibition of PAK, a regulator of the actin cytoskeleton, completely rescued the responsiveness of Gfi1b-null megakaryocytes to ligands, but not their ability to form proplatelets. We conclude that Gfi1b controls major functions of megakaryocytes such as integrin-dependent cytoskeleton organization, spreading and migration through the regulation of PAK activity whereas the proplatelet formation defect in GFI1B-deficient megakaryocytes is due, at least partially, to an insufficient α-tubulin content.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / chemistry
  • Actins / metabolism
  • Animals
  • Cell Differentiation / genetics
  • Cells, Cultured
  • Cytoskeleton / metabolism*
  • Gene Expression Profiling
  • Genetic Association Studies
  • Integrins / metabolism*
  • Megakaryocytes / drug effects
  • Megakaryocytes / metabolism*
  • Megakaryocytes / pathology
  • Megakaryocytes / ultrastructure
  • Mice
  • Mice, Knockout
  • Microtubules / metabolism
  • Phenotype
  • Platelet Count
  • Protein Kinase Inhibitors / pharmacology
  • Protein Multimerization
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins / metabolism*
  • Repressor Proteins / genetics*
  • Repressor Proteins / metabolism*
  • Signal Transduction*
  • Thrombocytopenia / blood
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / genetics
  • Thrombocytopenia / metabolism
  • Transcriptome

Substances

  • Actins
  • Gfi1b protein, mouse
  • Integrins
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins
  • Repressor Proteins

Grants and funding